Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 27% ± 13% | |
lung | 7 studies | 26% ± 12% | |
peripheral blood | 5 studies | 25% ± 6% | |
heart | 4 studies | 23% ± 4% | |
intestine | 4 studies | 17% ± 1% | |
adipose | 4 studies | 18% ± 1% | |
pancreas | 3 studies | 22% ± 5% | |
placenta | 3 studies | 22% ± 2% | |
liver | 3 studies | 27% ± 9% | |
kidney | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2939.06 | 1445 / 1445 | 100% | 35.60 | 183 / 183 |
lung | 100% | 3490.42 | 578 / 578 | 100% | 32.04 | 1155 / 1155 |
liver | 100% | 3716.53 | 226 / 226 | 100% | 30.43 | 405 / 406 |
breast | 100% | 3050.14 | 459 / 459 | 100% | 33.05 | 1115 / 1118 |
bladder | 100% | 3419.43 | 21 / 21 | 100% | 25.22 | 502 / 504 |
prostate | 100% | 2494.71 | 245 / 245 | 100% | 23.97 | 500 / 502 |
ovary | 100% | 1675.29 | 180 / 180 | 100% | 16.36 | 428 / 430 |
thymus | 100% | 2812.06 | 653 / 653 | 99% | 24.14 | 601 / 605 |
stomach | 100% | 2566.74 | 359 / 359 | 99% | 26.57 | 284 / 286 |
kidney | 100% | 2758.10 | 89 / 89 | 99% | 26.35 | 894 / 901 |
uterus | 100% | 2636.96 | 170 / 170 | 99% | 25.77 | 455 / 459 |
intestine | 100% | 4157.54 | 966 / 966 | 99% | 24.39 | 522 / 527 |
pancreas | 100% | 2679.89 | 328 / 328 | 98% | 26.41 | 175 / 178 |
adrenal gland | 100% | 3613.15 | 258 / 258 | 94% | 14.28 | 216 / 230 |
skin | 100% | 3492.03 | 1809 / 1809 | 94% | 22.98 | 442 / 472 |
brain | 92% | 1006.19 | 2428 / 2642 | 100% | 22.76 | 704 / 705 |
adipose | 100% | 3364.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.17 | 29 / 29 |
muscle | 100% | 9602.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3424.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.52 | 1 / 1 |
blood vessel | 100% | 2953.82 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2773.99 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 2792.46 | 834 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 7.65 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031293 | Biological process | membrane protein intracellular domain proteolysis |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0050776 | Biological process | regulation of immune response |
GO_0006509 | Biological process | membrane protein ectodomain proteolysis |
GO_0033619 | Biological process | membrane protein proteolysis |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031902 | Cellular component | late endosome membrane |
GO_0098553 | Cellular component | lumenal side of endoplasmic reticulum membrane |
GO_0098554 | Cellular component | cytoplasmic side of endoplasmic reticulum membrane |
GO_0005770 | Cellular component | late endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0016020 | Cellular component | membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0042500 | Molecular function | aspartic endopeptidase activity, intramembrane cleaving |
Gene name | SPPL2A |
Protein name | Signal peptide peptidase like 2A Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2) |
Synonyms | PSL2 PSEC0147 IMP3 |
Description | FUNCTION: Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in FASLG, ITM2B and TNF processing . Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus . Also responsible for the intramembrane cleavage of Fas antigen ligand FASLG, which promotes the release of the intracellular FasL domain (FasL ICD) . Essential for degradation of the invariant chain CD74 that plays a central role in the function of antigen-presenting cells in the immune system (By similarity). Plays a role in the regulation of innate and adaptive immunity . Catalyzes the intramembrane cleavage of the simian foamy virus envelope glycoprotein gp130 independently of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis . . |
Accessions | ENST00000558414.1 ENST00000698132.1 A0A8V8TLZ2 ENST00000698134.1 ENST00000698131.1 A0A8V8TLF6 ENST00000261854.10 A0A8V8TN76 H0YNA2 ENST00000559293.2 A0A8V8TLI3 A0A8V8TLY7 Q8TCT8 H0YNA7 ENST00000698133.1 ENST00000698135.1 ENST00000558934.1 |